This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dávila-Román, V. G. Articles by Schaff, H. V. Search for Related Content PubMed PubMed Citation Articles by Dávila-Román, V. G. Articles by Schaff, H. V.

Prevalence and severity of paravalvular regurgitation in the Artificial Valve Endocarditis Reduction Trial (AVERT) echocardiography study

Victor G. Dávila-Román, MD, FACC^*,*, Alan D. Waggoner, RDCS, MHS^*, Elizabeth D. Kennard, PhD, Richard Holubkov, PhD, W. R. Eric Jamieson, MD, Lars Englberger, MD^||, Thierry P. Carrel, MD^|| and Hartzell V. Schaff, MD^¶

^* AVERT Echocardiography Core Laboratory and the Cardiovascular Imaging and Clinical Research Core Laboratory, Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri
AVERT Coordinating Center, University of Pittsburgh, Pittsburgh, Pennsylvania
Department of Family and Preventive Medicine, School of Medicine, University of Utah, Salt Lake City, Utah
St. Paul's Hospital, Vancouver BC, Canada
^|| Inselspital Bern, Bern, Switzerland
^¶ Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota

View larger version (21K): [in a new window]   Figure 1 Kaplan-Meier curves for definite paravalvular regurgitation for all valves in the AVERT echocardiography substudy (both mitral and aortic valve replacement).